SkyePharma and Sanofi launch Xatral in Europe

SkyePharma (LSE:SKP; SKYE) and partner Sanofi- Synthelabo (Paris, France) launched Xatral XL, a sustained release once daily formulation of alfuzosin in Denmark, Sweden, the Netherlands and the U.K. X...